REFERENCES
1. Duley L. The Global Impact of Pre-eclampsia and Eclampsia. Semin Perinatol. 2009;33(3):130–7.
2. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: A WHO systematic analysis. Lancet Glob Health. 2014;2(6):323–33.
3. Gardosi J, Kady SM, McGeown P, Francis A TA. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ. 2005;331(1113–1117).
4. Iams JD, Goldenberg RL, Mercer BM, Moawad A, Thom E, Meis PJ, et al. The Preterm Prediction Study: recurrence risk of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1998;178(5):1035–40.
5. Lisonkova S, Joseph KS. Incidence of preeclampsia: Risk factors and outcomes associated with early-versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1-544.e12.
6. Weitzner O, Yagur Y, Weissbach T, Man El G, Biron-Shental T. Preeclampsia: risk factors and neonatal outcomes associated with early- versus late-onset diseases. J Matern Fetal Neonatal Med. 2018;6:1–5.
7. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. The Lancet. 2010;376(9741):631–44.
8. von Dadelszen P, Menzies JM, Payne B, Magee LA. Predicting Adverse Outcomes in Women with Severe Pre-eclampsia. Semin Perinatol. 2009;33(3):152–7.
9. Thangaratinam S, Allotey J, Marlin N, Dodds J, Cheong-See F, von Dadelszen P, et al. Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models. BMC Med. 2017;15(1):1–11.
10. Alanwar A, El Nour AA, El Mandooh M, Abdelazim IA, Abbas L, Abbas AM, et al. Prognostic accuracy of cerebroplacental ratio for adverse perinatal outcomes in pregnancies complicated with severe pre-eclampsia; a prospective cohort study. Pregnancy Hypertens. 2018;14(April):86–9.
11. El-Demiry NM, Maged AM, Gaafar HM, ElAnwary S, Shaltout A, Ibrahim S, et al. The value of fetal Doppler indices as predictors of perinatal outcome in women with preeclampsia with severe features. Hypertens Pregnancy. 2020;39(2):95–102.
12. Gómez-Arriaga PI, Herraiz I, López-Jiménez EA, Escribano D, Denk B, Galindo A. Uterine artery Doppler and sFlt-1/PlGF ratio: Prognostic value in early-onset pre-eclampsia. Ultrasound Obstet Gynecol. 2014;43(5):525–32.
13. Rani S, Huria A, Kaur R. Prediction of perinatal outcome in preeclampsia using middle cerebral artery and umbilical artery pulsatility and resistance indices. Hypertens Pregnancy. 2016;35(2):210–6.
14. Stubert J, Ullmann S, Dieterich M, Diedrich D, Reimer T. Clinical differences between early- and late-onset severe preeclampsia and analysis of predictors for perinatal outcome. J Perinat Med. 2014;42(5):617–27.
15. Lees C, Marlow N, Arabin B, Bilardo CM, Brezinka C, Derks JB. Perinatal morbidity and mortality in early-onset fetal growth restriction : cohort outcomes of the trial of randomized umbilical and fetal flow in Europe ( TRUFFLE ). Ultrasound Obstet Gynecol. 2013;(July):400–8.
16. Wang A, Rana S, Karumanchi SA. Preeclampsia: The Role of Angiogenic Factors in Its Pathogenesis. Physiology. 2009;24(3):147–58.
17. Karumanchi SA. Angiogenic factors in preeclampsia: From diagnosis to therapy. Hypertension. 2016;67(6):1072–9.
18. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med. 2016;374(1):13–22.
19. Chappell L, Duckworth S, Seed P, Griffin M, Myers J, Mackillop L, et al. Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia: A Prospective Multicenter Study. Circulation. 2013;128(19):2121–31.
20. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012;125(7):911–9.
21. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2012;206(1):58.e1-58.e8.
22. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97–104.
23. American College of Obstetricians and Gynecologists; Task Force on Hypertension in pregnancy. Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31.
24. Robinson H, Fleming J. A critical evaluation of sonar ‘crown-rump length’ measurements. Br J Obstet Gynaecol. 1975;82:702–10.
25. Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016;48(3):333–9.
26. Thangaratinam S, Allotey J, Marlin N, Mol BW, Von Dadelszen P, Ganzevoort W, et al. Development and validation of Prediction models for Risks of complications in Early-onset Pre-eclampsia (PREP): a prospective cohort study. Health Technol Assess. 2017;21(18).
27. Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements–a prospective study. Am J Obstet Gynecol. 1985;151(3):333–7.
28. Arduini D, Rizzo G. Normal values of Pulsatility Index from fetal vessels: a cross-sectional study on 1556 healthy fetuses. J Perinat Med. 1990;18(3):165–72.
29. Gómez O, Figueras F, Fernández S, Bennasar M, Martínez JM, Puerto B, et al. Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol. 2008 Aug;32(2):128–32.
30. ACOG Practice Bulletin No202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2020;135(6):1492–5.
31. Macones GA, Hankins GD V, Spong CY, Hauth J, Moore T. The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines. Obstet Gynecol. 2008 Sep;112(3):661–6.
32. Figueras F, Gratacos E. An integrated approach to fetal growth restriction. Best Pract Res Clin Obstet Gynaecol. 2017;38:48–58.
33. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach. Biometrics. 1988;44(3):837–45.
34. Orabona R, Gerosa V, Gregorini ME, Pagani G, Prefumo F, Valcamonico A, et al. The prognostic role of various indices and ratios of Doppler velocimetry in patients with pre-eclampsia. Clin Exp Hypertens. 2015;37(1):57–62.
35. Duhig KE, Myers J, Seed PT, Sparkes J, Lowe J, Hunter RM, et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. The Lancet. 2019 May;393(10183):1807–18.
36. Pinheiro CC, Rayol P, Gozzani L, dos Reis LM, Zampieri G, Dias CB, et al. The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia. Prenat Diagn. 2014;34(11):1084–92.
37. Simón E, Permuy C, Sacristán L, Zamoro-Lorenci MJ, Villalaín C, Galindo A, et al. sFlt-1/PlGF ratio for the prediction of delivery within 48 hours and adverse outcomes in expectantly managed early-onset preeclampsia. Pregnancy Hypertens. 2020;22(July):17–23.
38. Dröge LA, Perschel FH, Stütz N, Gafron A, Frank L, Busjahn A, et al. Prediction of Preeclampsia-Related Adverse Outcomes with the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine: A Real-World Study. Hypertension. 2021;1(February):461–71.
39. Duffy J, Cairns AE, Richards-Doran D, van ’t Hooft J, Gale C, Brown M, et al. A core outcome set for pre-eclampsia research: an international consensus development study. BJOG Int J Obstet Gynaecol. 2020 Nov;127(12):1516–26.